Skip to main content

Point72 Asset Management, L.P.

Position in MRNA — Moderna, Inc.

CIK 1603466 STAMFORD, CT

Position in MRNA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$10,050,475
+$10,050,475 QoQ
Shares Held
197,844
Ownership
0.050%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
5 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Derivatives in MRNA

reported options exposure · as of Mar 31, 2026
CallValue
$22,661,880
CallShares
446,100
PutValue
$3,571,240
PutShares
70,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Point72 Asset Management, L.P. holds $2,393,450,612 across 188 Biotechnology names. MRNA ranks #65 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MRNA

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,571,240 70,300
2026-03-31 $10,050,475 197,844
2026-03-31 $22,661,880 446,100
2025-12-31 $3,612,525 122,500
2025-12-31 $5,249,220 178,000
2025-09-30 $66,917,781 2,590,700
2020-12-31 $36,564,500 350,000
2020-09-30 $5,306,250 75,000